The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
In the patients with osteoporosis, bisphosphonates (BPs) are a golden standard treatment.
However, the bone turnover markers or the bone mineral density (BMD) are not improved in some
osteoporotic patients even though they have taken BPs and alfacalcidol more than several
years. In those case, the investigators better off prescribing BPs and Eldecalcitol, instead
of BPs and Alfacalcitol.